Natural Killer Cell Characteristics in Patients With Chronic Hepatitis B Virus (HBV) Infection Are Associated With HBV Surface Antigen Clearance After Combination Treatment With Pegylated Interferon Alfa-2a and Adefovir
Open Access
- 19 March 2015
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 212 (7) , 1042-1051
Abstract
Background. The role of natural killer (NK) cells in the process of hepatitis B virus (HBV) surface antigen (HBsAg) clearance and whether their phenotype is related to treatment outcome in patients with chronic hepatitis B are currently unknown. Methods. Patients with chronic hepatitis B (HBV DNA load, >17 000 IU/mL) were treated with pegylated interferon alfa-2a and adefovir for 48 weeks. NK cell phenotype and function were analyzed in 7 responders (defined as individuals with HBsAg clearance by week 72; 3 HBV e antigen [HBeAg]-positive and 4 HBeAg-negative), 7 matched nonresponders, and 7 healthy controls. Subsequently, 34 baseline samples from HBeAg-positive patients with chronic hepatitis B were analyzed. Results. During treatment, the percentage and absolute number of CD56bright NK cells increased significantly, whereas the percentage and absolute number of CD56dim NK cells decreased. At baseline, responders had a significantly lower expression of chemokine receptor CX3CR1 on CD56bright NK cells and inhibitory receptor NKG2A on CD56dim NK cells, compared with nonresponders. In addition, responders had higher CD56bright TRAIL expression and interferon γ production at end of treatment. These baseline differences were not found in HBeAg-positive patients who had HBeAg seroconversion without HBsAg clearance. Conclusions. Combination therapy significantly influences NK cell phenotype and function. Differences between patients with chronic hepatitis B with HBsAg clearance and nonresponders suggest that NK cells play a role in the clearance of HBsAg during interferon-based combination therapy.Keywords
This publication has 34 references indexed in Scilit:
- Natural killer inhibitory receptor expression associated with treatment failure and interleukin-28B genotype in patients with chronic hepatitis CHepatology, 2011
- Virus-Induced Transient Immune Suppression and the Inhibition of T Cell Proliferation by Type I InterferonJournal of Virology, 2011
- 278 AUGMENTED HEPATITIS B SPECIFIC T CELL RESPONSE AFTER CLEARANCE OF CHRONIC HEPATITIS BJournal of Hepatology, 2011
- Blockade of Immunosuppressive Cytokines Restores NK Cell Antiviral Function in Chronic Hepatitis B Virus InfectionPLOS Pathogens, 2010
- CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subsetBlood, 2010
- The Role of Chemokines in the Recruitment of Lymphocytes to the LiverDigestive Diseases, 2010
- Interferon-α–Induced TRAIL on Natural Killer Cells Is Associated With Control of Hepatitis C Virus InfectionGastroenterology, 2010
- CD94 surface density identifies a functional intermediary between the CD56bright and CD56dim human NK-cell subsetsBlood, 2010
- Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell–mediated liver damageJournal of Experimental Medicine, 2007
- Cytotoxic T lymphocyte responsiveness after resolution of chronic hepatitis B virus infection.Journal of Clinical Investigation, 1996